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Summary
Background: Tks5 regulates invadopodium formation, but the
precise timing during invadopodium lifetime (initiation, stabili-
zation, maturation) when Tks5 plays a role is not known.
Results: We report new findings based on high-resolution
spatiotemporal live-cell imaging of invadopodium precursor
assembly. Cortactin, N-WASP, cofilin, and actin arrive
together to form the invadopodium precursor, followed by
Tks5 recruitment. Tks5 is not required for precursor initiation
but is needed for precursor stabilization, which requires the
interaction of the phox homology (PX) domain of Tks5 with
PI(3,4)P2. During precursor formation, PI(3,4)P2 is uniformly
distributed but subsequently starts accumulating at the pre-
cursor core 3–4 min after core initiation, and conversely,
PI(3,4,5)P3 gets enriched in a ring around the precursor core.
SHIP2, a 50-inositol phosphatase, localizes at the invadopo-
dium core and regulates PI(3,4)P2 levels locally at the invado-
podium. The timing of SHIP2 arrival at the invadopodium
precursor coincides with the onset of PI(3,4)P2 accumulation.
Consistent with its late arrival, we found that SHIP2 inhibition
does not affect precursor formation but does cause decreases
in mature invadopodia and matrix degradation, whereas
SHIP2 overexpression increases matrix degradation.
Conclusions: Together, these findings lead us to propose a
newsequential model that provides novel insights intomolecu-
lar mechanisms underlying invadopodium precursor initiation,
stabilization, and maturation into a functional invadopodium.
Introduction
Invadopodia are actin-rich protrusive structures of cancer
cells, 0.05–1 mm in diameter and 0.5–10 mm long [1–3]. The pri-
mary function of these structures is to degrade extracellular
matrix (ECM), creating a passage that cancer cells can utilize
during metastasis [4–6], the leading cause of death among
cancer patients. Invadopodia are characterized by a core
containing several proteins, including cortactin, Tks5, cofilin,
N-WASP, Nck1, Arp2/3, p190RhoGAP, F-actin, and MT1-
MMP [2, 7–9], that is surrounded by a ring of other proteins: in-
tegrin a5 [10], Hic-5, paxillin, vinculin [6, 11], p190RhoGEF, and
RhoC activity [2]. One of the invadopodial core proteins, Tks5,*Correspondence: ved.sharma@einstein.yu.eduis essential for invadopodia and podosome formation in many
different cell types [12–16]. Tks5 directly binds to the ADAM
family proteases [12], N-WASP, dynamin-2, and Grb2 [14,
15]. In vivo, decreased Tks5 expression correlates with reduc-
tions in tumor growth, metastasis, and angiogenesis [17].
Tks5 contains a phox homology (PX) domain that binds the
membrane phosphoinositides PI(3)P and PI(3,4)P2 [12]. In Src-
transformedNIH 3T3 cells, Tks5 andPI(3,4)P2 localize to podo-
somes via a Grb2-dependent mechanism [14]. However,
podosomes and invadopodia are distinct matrix-degrading
structures with differences in molecular composition, dy-
namics, and structure [18–20]. In particular, invadopodia in
carcinoma cells contain the Nck1 adaptor protein but lack
Grb2 [20]. Furthermore, both localization of PI(3,4)P2 at inva-
dopodia and the precise timing of Tks5 arrival during invado-
podium assembly are unknown, and their involvement in
invadopodium assembly and maturation is not well described.
Furthermore, integrin-associated podosomes do not move
laterally in the cell membrane [14], whereas invadopodia in
carcinoma cells show rapid lateral movement there [9]. These
differences suggest differences between the molecular regu-
lation of invadopodium and podosome assembly and mem-
brane linkage as well as differences in the regulation of the
interaction between the PX domain of Tks5 and PI(3,4)P2.
So far, ten mammalian 50-phosphatases have been identified
[21], and one of these 50-phosphatases, synaptojanin-2, was
shown to regulate invadopodium formation in glioblastoma
cells [22]. SHIP2 overexpression was recently shown to in-
crease invadopodia number and matrix degradation in head
and neck cancer cells [23]. Therefore, studying the spatiotem-
poral localization and dynamics of these 50-phosphatases and
howthey regulatePI(3,4)P2 levelswouldyield important insights
into the molecular mechanisms of invadopodium formation.
Previous studies have demonstrated that invadopodium
assembly is a sequential process [7, 8], startingwith the forma-
tion of an invadopodium precursor that matures into a degra-
dation-competent invadopodium, but relatively little is known
about the early and intermediate stages of maturation during
which the invadopodium precursor is anchored to the mem-
brane and stabilized. In this study, we investigate the order
of arrival of different invadopodium core proteins (Tks5, cor-
tactin, N-WASP, cofilin, actin, and SHIP2) and PI(3,4)P2 during
invadopodium precursor assembly andmaturation using high-
resolution live-cell imaging. Our results yield novel insights
into how invadopodial core proteins and phospholipids coop-
erate to stabilize the invadopodium precursor, a key step for
carcinoma invasion and metastasis.
Results
Arrival Kinetics of Invadopodium Core Proteins during
Precursor Assembly
Given the key roles of invadopodia during carcinoma invasion
andmetastasis, it is critical to understand the order of arrival of
core invadopodial proteins during invadopodium precursor
assembly in carcinoma cells. We chose highly metastatic rat
mammary adenocarcinoma MTLn3 cells as a model because
these cells use epidermal growth factor (EGF)-dependent
Figure 1. Arrival Kinetics of Invadopodium Precursor Core Proteins during Precursor Assembly
(A, C, and E) MTLn3 cells showing cortactin- and Tks5- (A), cortactin- and N-WASP- (C), and cortactin- and cofilin- (E) positive invadopodia before (top
panels) and after (bottom panels) EGF stimulation (see Movies S1, S3, and S4). White arrows in the merge images point to examples of newly assembled
invadopodium precursors. Scale bars represent 10 mm.
(B, D, and F) Time-lapse montage of cortactin and Tks5 (B), cortactin and N-WASP (D), and cortactin and cofilin (F) fluorescence channels for newly assem-
bled invadopodium precursors. Red circles indicate the first appearance of precursor puncta in each channel. Time 0:00 corresponds to the EGF addition.
(G) Tks5, N-WASP, cofilin, and actin arrival delays with respect to cortactin during invadopodium precursor assembly. Red lines indicate mean with 95%
confidence interval. n = 17 (Tks5), 46 (N-WASP), 45 (cofilin), and 26 (actin) invadopodium precursors.
See also Figure S1.
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2080invadopodia [9] to invade and disseminate metastatic tumors
in vivo [5]. Furthermore, they make robust invadopodia when
plated on gelatin and/or fibronectin substrates in vitro, and
EGF stimulation of these cells induces the formation of invado-
podium precursors that mature and go on to degrade the
underlyingmatrix [2, 8]. To study relative arrival of core invado-
podial proteins in newly forming invadopodium precursors, we
stimulated MTLn3 cells with EGF and performed high-resolu-
tion live-cell fluorescence imaging, with frames every 3 s. First,
we transfected cells with TagRFP-cortactin and GFP-Tks5
and plated them on thin gelatin matrix [8, 24]. Within 1 min
of EGF stimulation, these cells formed many invadopodiumprecursors identified as cortactin- and Tks5-rich puncta
lacking protease activity (Figure 1A; see also Movie S1 avail-
able online). We analyzed the dynamics of fluorescence signal
at the site of newly forming invadopodium precursors and
found that cortactin localization preceded Tks5 localization
(Figure 1B). We tracked newly forming invadopodium precur-
sors in cortactin and Tks5 channels using the ‘‘Invadopodia
Tracker’’ ImageJ plugin [25] (Figure S1A; Movie S2) and
quantified the relative arrival of Tks5 with respect to cortactin;
we found that Tks5 appears approximately 20 s after cortactin
arrival (Figure 1G). To determine the relative arrival of N-WASP,
cofilin, and actin with respect to cortactin, we transfected cells
Figure 2. Tks5 Is Dispensable for Invadopodium Precursor Initiation but Is Required for Precursor Stability
(A) Control or Tks5 siRNA-treated cells were stimulatedwith 5 nM EGF for 1min and stained with N-WASP and cortactin antibodies to identify invadopodium
precursors (shown by white arrows).
(B) Quantification of invadopodium precursors (means 6 SEM) in control and Tks5 siRNA-treated cells. n = 19 (control siRNA) and 22 (Tks5 siRNA) cells.
(C) Stills from Movie S6 showing invadopodia stability. White arrows in control siRNA panel point to a stable invadopodium, whereas white arrows in Tks5
siRNA panels point to examples of unstable invadopodium precursors.
(D) Invadopodia lifetime histograms for control and Tks5 siRNA-transfected cells. Note the complete absence of stable invadopodia (lifetime > 60 min) in
Tks5 siRNA cells. n = 49 (control siRNA) and 60 (Tks5 siRNA) invadopodia.
(E and F) Representative invadopodium trajectories in control (E) and Tks5 siRNA-treated (F) cells. Numbers beside each trajectory indicate lifetime (min).
(G) Quantification of invadopodium motility as net distance per lifetime (means 6 SEM). n = 39 (control siRNA) and 49 (Tks5 siRNA) invadopodia.
See also Figure S2.
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2081with their plasmids and repeated time-lapse imaging as
described above (Figures 1C and 1E; Movies S3 and S4), and
we found that N-WASP, cofilin, and actin appear at the same
time as cortactin (Figures 1D, 1F, and S1B). Tracking of inva-
dopodium precursors and quantification confirmed that there
is no delay in N-WASP, cofilin, or actin arrival at the precursor
compared to cortactin (Figure 1G).
Next, we investigated the site where invadopodium precur-
sor assembly takes place. We found that some invadopodium
precursors initiate at the proximal tip of focal adhesions (Fig-
ures S1C and S1D; Movie S5), consistent with observations
made for podosome initiation [14, 26]. However, some invado-
podium precursors form with no nearby focal adhesion
(Figure S1E). In addition, unlike podosomes, which remain sta-
tionary, some invadopodia formed at focal adhesions are
motile (Figure S1F; [9]).Tks5 Is Not Required for InvadopodiumPrecursor Initiation
Because Tks5 arrives later at the invadopodium precursor
than other core components do, we speculated that Tks5
might not be important for invadopodium precursor assembly.
To test this hypothesis, first we knocked down Tks5 using
siRNA, and we found an efficient Tks5 reduction (w85%–
90%) (Figures S2A and S2B) with low cell-to-cell variability in
Tks5 KD levels (Figure S2C). To check Tks5 KD effect on inva-
dopodium precursor formation, we stimulated control and
Tks5 siRNA-treated cells with EGF for 1 min (the earliest time
that corresponds to a burst in precursor formation; [8]) and
fixed and stained them with N-WASP and cortactin antibodies
to identify invadopodium precursors. The number of invado-
podium precursors in Tks5 KD cells compared to the control
cells was unchanged (Figures 2A and 2B). We repeated this
experiment with a different set of invadopodium markers
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2082(cortactin, cofilin, and Arp2) and again found that the number
of invadopodium precursors is unaffected by Tks5 KD
(Figure S2D). These results indicate that Tks5 is not required
for initial assembly of invadopodium precursors in carcinoma
cells.
Tks5 Is Required for Invadopodium Precursor Stability
Although Tks5 is not required for invadopodium precursor
initiation, previous studies indicated that Tks5 KD reduced
the number of invadopodia/podosomes and degradation
area in many cell types [13–15]. Therefore, we hypothesized
that Tks5 might be important for invadopodium precursor sta-
bility and required for their maturation into functional invado-
podia [8]. We therefore performed long-duration time-lapse
imaging (one frame every 2 min for 10 hr) of control and Tks5
siRNA-treated cells, with TagRFP-cortactin as an invadopo-
diummarker. We found that compared to many stable invado-
podia in control cells, most of the invadopodia in Tks5 siRNA
cells were short lived (Figure 2C; Movie S6). Lifetime quantifi-
cation showed that control siRNA-treated cells had invadopo-
dia with a variety of lifetimes, ranging from very short lived
(<10 min), some staying tens of minutes, to a very stable pop-
ulation (w40%) staying for more than 1 hr (Figure 2D). In
contrast, most of the invadopodia in Tks5 siRNA-treated cells
were unstable, with more than 50% of the invadopodia exhib-
iting a lifetime of less than 10 min and none remaining longer
than 1 hr (Figure 2D). To examine individual invadopodia
motility, we plotted their x-y trajectories (Figures 2E and 2F)
and quantified net distance traveled by each invadopodium
divided by its lifetime [9]. This ratio was higher for invadopodia
in Tks5 siRNA cells compared to those in control cells (Fig-
ure 2G), indicating that invadopodia in Tks5 siRNA-treated
cells are more motile than those in control cells. Together,
these results indicate that Tks5 is necessary for stabilizing in-
vadopodium precursors and helping to localize their positions.
To check whether ECM degradation and protrusion into the
matrix might be required for invadopodium precursor stability,
we treated cells with GM6001, a pan-MMP inhibitor, to block
matrix degradation (Figure S2E) and examined invadopodia
motility. We found that GM6001-treated cells show invadopo-
dia lifetime distributions and motility similar to DMSO control
(Figures S2F–S2I), suggesting that ECM degradation is not a
requirement for precursor stability. Recently, reactive oxygen
species (ROS) were implicated in podosome/invadopodia for-
mation through a Tks5-dependent pathway [27]. To examine
this, we treated cells with a widely used ROS inhibitor, diphe-
nyleneiodonium chloride (DPI), and assayed for invadopodia
formation and matrix degradation. We found that cells treated
with DPI concentration as high as 20 mM made robust
invadopodia and degraded matrix, similar to DMSO control
(Figure S2J), suggesting that ROS does not play a role in inva-
dopodium precursor formation and stability in MTLn3 cells.
Interaction of the PX Domain of Tks5 with PI(3,4)P2
Stabilizes Invadopodium Precursors
Because the PX domain of Tks5 binds PI(3)P and PI(3,4)P2 [12]
and PI(3,4)P2, but not PI(3)P, localizes at podosomes in Src-
transformed NIH3T3 cells [14], we hypothesized that the inter-
action of the PX domain of Tks5 with PI(3,4)P2 is required for
invadopodium precursor stability and maturation. To test
this, we generated a PI(3,4)P2 binding-deficient Tks5-R42A/
R93A mutant (Figure S3A) [12, 14]. We performed KD-rescue
experiments, in which we depleted endogenous Tks5 and
rescued with either GFP or RNAi-resistant GFP-Tks5 or GFP-Tks5-R42A/R93A. Western blot analysis (Figure 3A) showed
efficient endogenous Tks5 KD (w85%–90%) in all Tks5 siRNA
samples. GFP-Tks5 was expressed atw30%–40% of endog-
enous Tks5 and was found to be sufficient to rescue the inva-
dopodia number and degradation area to levels seen with
control siRNA (Figures S3B–S3G). The mutant was also ex-
pressed at similar levels (w30%–40% of endogenous Tks5).
Consistent with observations made for invadopodia/podo-
somes in other cell types [13–15], we also found that Tks5
KD in MTLn3 cells leads to a dramatic decrease in the number
of mature invadopodia (cortactin- and Tks5-positive puncta
colocalizing with degradation hole) and degradation area.
This decrease was rescued with wild-type Tks5 but not with
the lipid binding-deficient Tks5-R42A/R93A mutant (Figures
S3F and S3G). These results demonstrate that the interaction
of Tks5 with PI(3,4)P2 through its PX domain is necessary for
precursor maturation into functional invadopodia.
To visualize invadopodium precursor stability directly, we
performed high-resolution live-cell time-lapse imaging of cells
under the four Tks5 KD-rescue conditions. Cells were stimu-
lated with EGF to induce precursor initiation and followed for
30 min to assess their stability (Figures 3B–3E; Movie S7).
Tks5 KD led to a decrease in the number of cells with new in-
vadopodium precursors that were stable, which was rescued
with the wild-type Tks5, but not with Tks5-R42A/R93A mutant
(Figure 3F). These results are the first direct evidence that the
interaction of the PX domain of Tks5 with PI(3,4)P2 is required
for invadopodium precursor stability.
We observed that the Tks5-R42A/R93A mutant localizes at
invadopodium precursors (Figure S3E). Quantification showed
a 75% reduction in the mean fluorescence intensity of mutant
compared to wild-type Tks5 (Figure S3H), indicating that
although the mutant can get recruited to precursors, possibly
via N-WASP binding [14], the precursor cannot grow further
unless it is stabilized by Tks5-PI(3,4)P2 interaction.
PI(3,4)P2 Arrival Kinetics during Invadopodium Precursor
Assembly
We next examined PI(3,4)P2 localization in MTLn3 cells with
a PI(3,4)P2-specific probe, TAPP1-PH [28]. We found that
PI(3,4)P2 localizes at the invadopodium core (Figure 4A), with
15% more enrichment at the core compared to the surround-
ing region (Figure 4E). Since Tks5 also binds PI(3)P [12], we
checked PI(3)P localization using a PI(3)P-specific probe,
2xHrs-FYVE [29], and found that PI(3)P did not localize to the
invadopodium core (Figures 4B and 4E). We also examined
PI(4,5)P2 localization using a PI(4,5)P2-specific probe, YFP-
PH-PLCd1 [29]. PI(4,5)P2 localization was not observed at
the invadopodium core, but the signal was enriched at the
plasma membrane and sometimes adjacent to invadopodia
(Figure 4C), although quantification showed no significant
PI(4,5)P2 accumulation around the core (Figure 4E). We
confirmed the endogenous PI(3,4)P2 and PI(4,5)P2 localiza-
tions with phospholipid-specific antibodies [30, 31] and found
similar results (Figures S4A and S4B).
Because the amount of PI(4,5)P2 (in the mM range) in cells is
orders of magnitude higher than the amount of PI(3,4,5)P3 and
PI(3,4)P2 (both in the mM range) [32], it is conceivable that any
changes in PI(4,5)P2 levels, due to PI(3,4,5)P3 and subsequent
PI(3,4)P2production,wouldbenegligible compared tochanges
observed inPI(3,4)P2 andPI(3,4,5)P3. To investigate this further,
we looked at PI(3,4,5)P3 localization at the invadopodiumusing
twoPI(3,4,5)P3-specificmarkers,Akt-PH [33] andGrp1-PH [29].
BothmarkersshowedadistinctPI(3,4,5)P3 ringaround the core
Figure 3. Binding of the PX Domain of Tks5 with PI(3,4)P2 Is Required for Invadopodium Precursor Stability and Maturation
(A) Western blot showing Tks5 KD-rescue in all the four conditions.
(B–E) Stills fromMovie S7 for the four Tks5 KD-rescue conditions, showing precursor stability. Note that EGF stimulates invadopodium precursor formation
in all conditions (column ‘‘3 min after EGF’’) but that precursors are stable only in conditions (B) and (D) and disappear in conditions (C) and (E) (column
‘‘30 min after EGF’’). Scale bar represents 10 mm.
(F) Quantification of cells showing newly forming invadopodium precursors that were stable (i.e., remained until the end of the movie, 30 min). Pairwise sta-
tistical comparisons were made using Fisher’s exact test in GraphPad Prism. n = 48, 34, 37, and 59 cells analyzed for the four Tks5 KD-rescue conditions,
respectively. The difference between Tks5 KD+GFP and Tks5KD+R42A/R93A was not significant (p = 0.154).
See also Figure S3.
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region less than 1 (Figures 4D, 4E, and S4C). Therefore, unlike
PI(3,4)P2, which is enriched at the core, PI(3,4,5)P3 is found en-
riched in a ring around the core, and PI(4,5)P2 patches are seen
in close proximity to invadopodia.
To investigate the timing of PI(3,4)P2 recruitment to the
plasma membrane during precursor assembly, we used total
internal reflection fluorescence (TIRF) microscopy to image
TagRFP-cortactin- andGFP-TAPP1-PH-transfected cells after
EGF stimulation. We found no enrichment of PI(3,4)P2 at the
invadopodium precursor; rather, it was homogeneously
distributed throughout the first 3 min of precursor assembly
(Figure S4D). To investigate the possibility that PI(3,4)P2 accu-
mulation at the precursor is a late event, we extended our TIRF
imaging rate to frames every 1 min and found that PI(3,4)P2
started accumulating at the precursors approximately 4 min
after cortactin arrival (Figures 4F and 4G). These results indi-
cate that low basal levels of PI(3,4)P2 support initial precursor
assembly, followed by an enrichment of PI(3,4)P2 at the inva-
dopodium as it matures.
PI(3,4)P2 Sequestration Leads to a Dose-Dependent
Decrease in the Number of Invadopodia and Matrix
Degradation
To investigate whether PI(3,4)P2 is required for invadopodium
formation, we used the overexpression of TAPP1-PH as astrategy for PI(3,4)P2 sequestration and thereby depletion of
PI(3,4)P2. Similar strategies have previously been used for
the sequestration of PI(4,5)P2 and PI(3,4,5)P3 [33–35]. We
found that cells expressing high levels of TAPP1-PH and
thereby sequestering most of the free PI(3,4)P2 did not form
any invadopodia and failed to degrade matrix (a phenotype
similar to Tks5 KD; Figures S3F and S3G), whereas cells ex-
pressing low to moderate levels of TAPP1-PH formed normal
invadopodia and degraded matrix (Figures 5A–5C). TAPP1-
PH overexpression was also shown to inhibit podosomes in
Src-transformed cells [14]. These results indicate that, like
Tks5, free PI(3,4)P2 levels are important for invadopodium for-
mation and maturation. To specifically check the role of PI(3,4)
P2 in precursor formation, we measured invadopodium pre-
cursors in low- and high-TAPP1-PH-expressing cells and
found no difference (Figure 5D), suggesting that PI(3,4)P2
primarily plays a role in stabilizing the precursor, not in its
initiation.
SHIP2 Localizes at the Invadopodium Core, and Its Arrival
Coincides with PI(3,4)P2 Accumulation
PI(3,4)P2 is primarily made in cells via dephosphorylation of
PI(3,4,5)P3 by a 5
0-inositol phosphatase [21] (Figure S5A).
Recently, it was reported that SHIP2 is highly expressed in
breast cancer cells, enhances metastasis [36], and leads
to an increase in invadopodia and degradation area [23];
Figure 4. PI(3,4)P2 Accumulation at the Invadopodium Precursor Is a Late Event
(A–D) Cells were transfected with GFP-TAPP1-PH (A), Venus-2xHrs-FYVE (B), GFP-PLCd1-PH (C), or GFP-Akt-PH (D), plated on 405-gelatin matrix, and
stained with cortactin and Tks5 antibodies to identify invadopodia. Insets show zoom images of invadopodia in each panel. Scale bars represent 10 mm.
(E) Quantification of phospholipid fluorescence intensities (means 6 SEM) at the invadopodium core/surrounding region. n = 21 (TAPP1-PH), 24 (2xHrs-
FYVE), 21 (PLCd1-PH), and 19 (Akt-PH) invadopodia.
(F) Time-lapse montage of PI(3,4)P2 accumulation kinetics during invadopodium precursor assembly by TIRF microscopy. Red circles indicate the first
frame of cortactin and PI(3,4)P2 appearance. Time 0 corresponds to the appearance of the cortactin punctum.
(G) Quantification of PI(3,4)P2 accumulation delay with respect to cortactin. Red lines indicate mean with 95% confidence interval. n = 44 precursors.
See also Figure S4.
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dia and whether SHIP2-mediated PI(3,4)P2 regulation is local
or global have not been studied. Therefore, we checked
whether MTLn3 cells express SHIP2. Western blots showed
that these cells do indeed express SHIP2, but not SHIP1 (Fig-
ure 6A), a closely related isoform. They also do not express
synaptojanin-2 (Figure S5B), another 50-phosphatase, impli-
cated previously in the regulation of invadopodia and
podosomes [14, 22]. Next, we examined the localization of
endogenous SHIP2 using a SHIP2 antibody and found that
SHIP2 localizes at the invadopodium core (Figure 6B). This
localization was further confirmed by localization of a GFP-
SHIP2 construct (Figure 6C).
To investigate the SHIP2 arrival kinetics during invadopo-
dium precursor formation, we imaged TagRFP-cortactin-
and GFP-SHIP2-transfected cells stimulated with EGF by
TIRF microscopy. We did not observe SHIP2 arrival during
the first 3 min of precursor assembly (Figure S5C). Therefore,
we extended our TIRF imaging rate to frames every 1 min
and found that SHIP2 arrived at the invadopodium precursor
approximately 3–4 min after cortactin arrival (Figures 6Dand 6E), the time window coinciding with the start of
PI(3,4)P2 accumulation. Simultaneous arrival of SHIP2 and
PI(3,4)P2 was further confirmed by imaging GFP-SHIP2 and
RFP-TAPP1-PH in the same cell (Figures S5D and S5E).
Furthermore, we observed a 10% decrease in PI(3,4,5)P3
levels at the core/surrounding region after SHIP2 arrival (Fig-
ures S5F and S5G). Taken together, these results strongly
suggest that newly forming PI(3,4)P2 at the invadopodium
precursor is generated from PI(3,4,5)P3 by local SHIP2 acti-
vity arriving after the initial core protein assembly at the
precursor.
SHIP2 Regulates Invadopodium Precursor Maturation by
Modulating PI(3,4)P2 Levels Locally at the Invadopodium
To investigate whether SHIP2 phosphatase activity regulates
invadopodium precursor formation and maturation, we
treated cells with a specific SHIP2 inhibitor, AS1949490
[37]. We found that PI(3,4)P2 levels in the whole cell and at
the invadopodia decreased by 50% (Figures S5H–S5J).
Furthermore, cells treated with SHIP2 inhibitor showed no
change in invadopodium precursors, but mature invadopodia
Figure 5. PI(3,4)P2 Sequestration Causes Significant Reductions in Invadopodium Formation and Matrix Degradation
(A) Cells were transiently transfected with GFP-TAPP1-PH, plated on 405-gelatin, and stained with cortactin and Tks5 antibodies. An area with cells having
varying expression levels of TAPP1-PH is shown using rainbow lookup table (LUT). Cell outlines with no (black), low (purple), moderate (cyan), and high (red)
TAPP1-PH levels are shown. Scale bar represents 10 mm.
(B and C) Scatterplots showing the effect of TAPP1-PH overexpression on cells’ ability to form invadopodia (B) and degrade matrix (C). Red lines are linear
regression fit. n = 73 cells.
(D) Quantification of invadopodium precursors per cell (means6 SEM) in low (lower 25th percentile) and high (upper 25th percentile) TAPP1-PH-expressing
cells, indicating that PI(3,4)P2 sequestration does not affect precursor formation. n = 20 (low) and 20 (high) cells.
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2085and degradation area were significantly decreased (Figures
7A–7D). Similar results were obtained when SHIP2 was
depleted with shRNA (Figures S6A–S6E). SHIP2 inhibition
also showed a 33% decrease in average invadopodium life-
time (Figure 7E), by increasing the number of short-lived
(1–10 min) invadopodia and decreasing the number of long-
lived (>1 hr) invadopodia (Figure 7F). Moreover, SHIP2 inhi-
bition led to a 50% decrease in Matrigel invasion of cells (Fig-
ure S6F), an effect that can be attributed to similar reduction
observed in matrix degradation ability of these cells under
SHIP2 inhibition (Figures 7D and S6E). As an alternative, to
check the role of SHIP2 phosphatase activity in PI(3,4)P2 gen-
eration and matrix degradation, we overexpressed either
wild-type SHIP2 or phosphatase-inactive SHIP2-D608A
mutant [38] in MTLn3 cells. We found that both PI(3,4)P2
levels and matrix degradation were increased approximately
2.5-fold with wild-type SHIP2, but not with SHIP2-D608A
mutant (Figures S6G and S6H).
Taken together, these results, consistent with the late arrival
(3–4 min after precursor initiation) of SHIP2, suggest that
SHIP2 phosphatase activity plays a critical role in modulating
PI(3,4)P2 levels, invadopodium stability, and maturation, but
not in precursor initiation.The Invadopodium Is a Highly Dynamic Structure
Because some invadopodium precursors were found to
initiate at the proximal tip of focal adhesions (Figures S1C–
S1D; Movie S5), we further investigated the role of focal adhe-
sions in invadopodium stability by performing high-resolution
time-lapse analysis. We found that stable invadopodia were
associated with a ring of focal adhesion proteins (vinculin
and talin) around the invadopodium core (Figures S6I and
S6J; Movie S8); therefore, we think that focal adhesion rings
are important for invadopodium anchoring and stability,
similar to observations made for invadopodia in head and
neck cancer cells [11]. Interestingly, we saw oscillations in
focal adhesion ring proteins occurring in synchrony with cor-
tactin oscillations (time period, 10 min) (Figure S6K), and
similar to cortactin-cofilin oscillations observed in invadopo-
dia inMDA-MB-231 cells during the dynamic extension/retrac-
tion cycle of invasive protrusions [3]. Therefore, not only are
the recruitment order and timing of invadopodium core pro-
teins and PI(3,4)P2, observed here in invadopodia, different
from those in podosomes [14, 39], there are key differences
in the dynamics of these two structures: podosomes do not
move laterally in the cell membrane and have not been shown
to display oscillations in assembly and protrusion [14],
Figure 6. SHIP2 Arrival Coincides with the Beginning of PI(3,4)P2 Accumulation at the Invadopodium Precursor
(A) MTLn3 whole-cell lysate was analyzed for the SHIP2 and SHIP1 expression levels by western blotting. Rat hematopoietic RBL-2H3 whole-cell lysate was
used as a positive control for SHIP1. Second lane in the top membrane shows 250, 150, and 100 kDa marker bands.
(B) Endogenous SHIP2 distribution checked by staining cells with cortactin and SHIP2 antibodies. White arrowheads show the colocalization of SHIP2, cor-
tactin, and degradation holes. Scale bar represents 10 mm.
(C) Cells were transfected with GFP-SHIP2 and stained with cortactin and Tks5 antibodies. White arrows show colocalization of SHIP2, cortactin, Tks5, and
degradation holes. Scale bar represents 10 mm.
(D) Time-lapse montage of SHIP2 arrival kinetics during invadopodium precursor assembly by TIRF microscopy. Red circles indicate the first frame of cor-
tactin and SHIP2 appearance. Time 0 corresponds to the appearance of the cortactin punctum.
(E) Quantification of SHIP2 arrival delay with respect to cortactin. Red lines indicate mean with 95% confidence interval. n = 60 precursors.
See also Figure S5.
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and S6K; Movie S8; [3, 9]).
Discussion
A Model for Carcinoma Cell-Specific Invadopodium
Assembly and Regulation
Based on the results reported here for carcinoma cells, we
propose a novel sequential model of invadopodium assembly
(Figure 7G). During invadopodium precursor initiation, cortac-
tin acts as a scaffold to bring cofilin and N-WASP together to
form the initial invadopodium precursor core. Since actin was
found to arrive together with cortactin, the cortactin-actin
complex may also act as a scaffold to bring in cofilin and
N-WASP. This initial assembly step is followed by the arrival
of Tks5, possibly via binding to N-WASP [14]. PI(3,4)P2 does
not participate during this initial Tks5 recruitment to precursor
complex, as the PI(3,4)P2 binding-deficient Tks5 mutant re-
tains the ability to localize to precursors and PI(3,4)P2 seques-
tration does not affect precursor formation. Because PI(3,4)P2
is distributed homogeneously at the plasma membrane and
no PI(3,4)P2 enrichment is seen at the site of precursor
assembly until 3–4 min after the start of precursor formation,
we propose that initially precursor binds weakly to the
plasma membrane via the interaction of the PX domain of
Tks5 with basal PI(3,4)P2 and is possibly aided by the associ-
ation of N-WASP with PI(4,5)P2 [40]. This is followed by an
increase in actin barbed-end activity and polymerization [8]
and recruitment of SHIP2 to the invadopodium precursor.
SHIP2 recruitment leads to PI(3,4)P2 enrichment at the inva-
dopodium precursor, which stabilizes the precursor core by
association with PI(3,4)P2 via Tks5 binding. This last stephas the effect of priming the precursor for maturation and
matrix degradation as described in previous studies (Fig-
ure 7G; [2, 3, 8, 13]).
This new invadopodium-specificmodel is attractivebecause
it helps explain the more dynamic behavior of invadopodia
in carcinoma cells as compared to podosomes in other cell
types. For example, since the binding interaction between
Tks5 and PI(3,4)P2 is reversible and this destabilizes the
precursor, anchorage of the precursor to the membrane as
well as core protein composition can oscillate under the
influence of changes in EGFR and NHE1 signaling, as shown
previously [3]. In addition, the proposed model is consistent
with the recently reported role of PI3K signaling in invadopo-
dium formation [23, 33], another rapidly reversible signaling
pathway.
Differences between the Carcinoma Cell-Specific
Invadopodium Model and Previous Work
In podosomes, the assembly order of the core relative to the
arrival of Tks5 is different from that observed here for invado-
podia. In fibroblast podosomes, Tks5 forms a complex with
Grb2 and PI(3,4)P2 in advance of the recruitment and assembly
of the core proteins [14]. In the smooth muscle cell podo-
somes, Tks5 is proposed to be a key scaffold for the
recruitment of the core proteins [39]. However, our results in
carcinoma cell invadopodia indicate that the cortactin-actin
complex acts as the initial scaffold that brings together
N-WASP and cofilin to form the invadopodium precursor
core complex. Numerous studies have demonstrated that
cortactin can directly bind to cofilin [8] and N-WASP [41].
Only after the precursor assembles does Tks5 get recruited
to it, possibly via N-WASP interaction [14].
Figure 7. SHIP2 Regulates Invadopodia Lifetime and Maturation
(A) DMSO-treated or 10 mM SHIP2 inhibitor AS1949490-treated cells were plated on 405-gelatin and stained with cortactin and Tks5 antibodies to identify
invadopodia. Scale bar represents 20 mm.
(B–D) Quantification of invadopodium precursors per cell; n = 91 (DMSO) and 67 (SHIP2 inhibitor) cells (B); mature invadopodia per cell, n = 91 (DMSO)
and 67 (SHIP2 inhibitor) cells (C); and degradation area per field of view, n = 25 (DMSO) and 26 (SHIP2 inhibitor) fields of view (D). Values shown are
means 6 SEM.
(E) Average invadopodia lifetime (means 6 SEM) in DMSO-treated and 10 mM SHIP2 inhibitor-treated cells. n = 225 (DMSO) and 208 (SHIP2 inhibitor) inva-
dopodia in (E) and (F).
(F) Invadopodia lifetime distributions in cells treated with DMSO or 10 mM SHIP2 inhibitor.
(G) A sequential model of invadopodium precursor assembly. Cofilin, cortactin, actin, and N-WASP arrive together to form the invadopodium precursor,
followed by Tks5 arrival, which stabilizes the precursor by binding to basal PI(3,4)P2 at the plasma membrane. This is followed by a burst in actin
barbed-end activity [13] and recruitment of SHIP2 at the precursor, which results in local PI(3,4)P2 production at the precursor. Increased PI(3,4)P2 produc-
tion supports a growing invadopodium precursor, leading to its maturation and matrix degradation.
See also Figures S5 and S6.
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2087Another difference with previous work is the absence of
PI(4,5)P2 localization at the invadopodium core. The absence
of PI(4,5)P2 at the invadopodium core is consistent with the
observation made for the podosomes of Src-transformed
NIH 3T3 cells [14]. However, PI(4,5)P2 localization was re-
ported at invadopodia in human MDA-MB-231 cells [35]. On
closer examination of Figure 1 in [35], we found that our data
are consistent with that previous study in the sense that
PI(4,5)P2 does not localize at the invadopodium core but
PI(4,5)P2 patches are seen in close proximity around the inva-
dopodium core, as seen in our study. This suggests that PI(4,5)
P2 may play a role in recruitment of PI(4,5)P2 binding proteins,such as N-WASP, to the vicinity of the assembling precursor
core but that it does not directly function in the final anchoring
of the core complex to the membrane.
SHIP2 Recruitment and the Role of Other 50-Phosphatases
in PI(3,4)P2 Generation at Invadopodia
SHIP2 has been shown to interact with a number of mole-
cules—p130Cas [42], RhoA [43], filamin [44], intersectin [38],
and vinexin [45]. Any one of these molecules is a potential
candidate for SHIP2 recruitment to invadopodium precursors.
Among these molecules, RhoA is not active at the invadopo-
dium core in MTLn3 cells [2], and knockdown of p130Cas
Current Biology Vol 23 No 21
2088using siRNA showed no difference in invadopodia formation
and cells’ ability to degrade matrix (data not shown). There-
fore, we propose that filamin, intersectin, vinexin, or yet
another unidentified SHIP2 binding partner might be recruiting
SHIP2 to the invadopodium precursor; this will need to be
further explored in future studies.
Here we report for the first time that SHIP2 localizes at the
invadopodium core and regulates PI(3,4)P2 levels locally at
the invadopodium. Our results indicate that SHIP2 arrival at
the invadopodium precursor coincides with the beginning of
PI(3,4)P2 enrichment at the precursor. We also found that the
carcinoma cells studied here do not express either SHIP1, a
closely related SHIP2 isoform, or synaptojanin-2, another
50-phosphatase. Based on these results in carcinoma cells,
we propose that SHIP2 50-phosphatase activity is a key
regulator of PI(3,4)P2 levels locally at invadopodia. However,
we did find synaptojanin-2 expression in metastatic human
MDA-MB-231 cells (Figure S5B), another triple-negative breast
carcinoma cell. Therefore, it is possible that differentmolecular
subtypes of carcinoma cells may employ additional 50-phos-
phatases or a combination of 50-phosphatases to regulate
PI(3,4)P2 levels at invadopodia. Future studies are necessary
to evaluate the role of other 50-phosphatases [21], their coordi-
nation in PI(3,4)P2 generation at invadopodia, and their individ-
ual contributions to the invasive and metastatic phenotype.
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